Učitavanje...
Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen
Fatal interstitial lung disease (ILD) is one of the rare side effects of Panitumumab. Both fatal and non-fatal ILD have been reported mainly in the Japanese population. We report a case of a nonsmoking Caucasian man with the diagnosis of metastatic rectal cancer (K-RAS wild-type) who developed fatal...
Spremljeno u:
| Izdano u: | Ecancermedicalscience |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cancer Intelligence
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027982/ https://ncbi.nlm.nih.gov/pubmed/30034518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.841 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|